CORE--ANALYTIC
核心--分析
基本信息
- 批准号:7626295
- 负责人:
- 金额:$ 20.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs disease modelAnimalsBioinformaticsBloodBrainBrain regionCatalogingCatalogsCluster AnalysisCustomDiscriminationElectronsEnsureFutureGasesGene ExpressionGenesHippocampus (Brain)Hormone AntagonistsHormonesIndividualLiquid substanceMass Spectrum AnalysisMenopauseModelingMusNumbersPathway interactionsPatternPattern RecognitionPerimenopausePharmacologic SubstancePlasmaPolymerase Chain ReactionProcessProgesteroneProteinsPurposeRNA ProcessingRadioimmunoassayRattusResearchResearch PersonnelReverse Transcriptase Polymerase Chain ReactionSamplingScienceSerumServicesSolutionsSpecimenSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTimeTissue BankingTissue SampleTissuesTranslational ResearchUrineUterusbrain tissuecomputational chemistrydetectorhormone metabolisminhibitor/antagonistionizationmemberprofessorprogramsresearch study
项目摘要
Core C: Analytic
The Analytical Core, under the direction of Dr. Nouri Neamati, Assistant Professor of
Pharmaceutical Sciences, will process, bank, and analyze all tissues and appropriate samples for
research purposes for use in this Program Project. The tissues as well as fluid, specimens including
blood, serum, and urine will be collected where needed for individual investigators with hypothesis
driven translational research. The Analytical Core will provide the following services where
appropriate:
1) Macroarray analysis of 100 highly relevant customized genes using SuperArray platform.
2) Real-Time PCR for selected genes.
3) Mass Spectrometry including MALDI and MS/MS analysis for selected samples.
4) Progesterone and metabolite analysis by Gas Chromatograph with Mass Selective Detector
utilizing Electron Impact ionization, and 5) Quantitative analysis of progesterone and metabolites by
radioimmunoassays.
核心C:分析
分析核心,在大学助理教授Nouri Neamati博士的指导下
制药科学部将处理、储存和分析所有组织和适当样本,
用于本项目的研究目的。组织和液体,标本包括
将在需要时采集血液、血清和尿液,供个体研究者假设
推动翻译研究。分析核心将提供以下服务,
适当的:
1)使用SuperArray平台对100个高度相关的定制基因进行宏阵列分析。
2)选择基因的实时PCR。
3)质谱法,包括选定样品的MALDI和MS/MS分析。
4)用气相色谱-质量选择检测器分析孕酮和代谢产物
利用电子碰撞电离,和5)通过
放射免疫测定
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NOURI NEAMATI其他文献
NOURI NEAMATI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NOURI NEAMATI', 18)}}的其他基金
Preclinical Development of First-in-Class NDUFS7 Antagonists for the Treatment of Pancreatic Cancer
用于治疗胰腺癌的一流 NDUFS7 拮抗剂的临床前开发
- 批准号:
10684845 - 财政年份:2022
- 资助金额:
$ 20.37万 - 项目类别:
Preclinical Development of First-in-Class GSTO1 Degraders for Colorectal Cancer
首创的结直肠癌 GSTO1 降解剂的临床前开发
- 批准号:
10675586 - 财政年份:2022
- 资助金额:
$ 20.37万 - 项目类别:
gp130 as a novel therapeutic target in ovarian cancer
gp130作为卵巢癌的新治疗靶点
- 批准号:
8797755 - 财政年份:2015
- 资助金额:
$ 20.37万 - 项目类别:
gp130 as a novel therapeutic target in ovarian cancer
gp130作为卵巢癌的新治疗靶点
- 批准号:
8994723 - 财政年份:2015
- 资助金额:
$ 20.37万 - 项目类别:
gp130 as a novel therapeutic target in ovarian cancer
gp130作为卵巢癌的新治疗靶点
- 批准号:
9903250 - 财政年份:2015
- 资助金额:
$ 20.37万 - 项目类别:
High Throughput Screen for Myotonic Dystrophy Type 1
1 型强直性肌营养不良的高通量筛查
- 批准号:
8209483 - 财政年份:2011
- 资助金额:
$ 20.37万 - 项目类别:
相似海外基金
Elucidation of mucosal healing mechanisms through the construction of a human Crohn 's disease model
通过构建人类克罗恩病模型阐明粘膜愈合机制
- 批准号:
20K08378 - 财政年份:2020
- 资助金额:
$ 20.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




